EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Chorus line in oral squamous cell carcinoma: How stromal and immune players orchestrate tumor progression (Review)

Eliano Cascardi, Mario Della Mura, Nicoletta Sgarro, Silvia Minei, Gerardo Cazzato, Eugenio Maiorano, Lorenzo Lo Muzio, Maria Eleonora Bizzoca, Fábio França Vieira E Silva, Eleonora Lo Muzio, Mario Dioguardi, Andrea Ballini

International Journal of Molecular Medicine · 2026

DOI: 10.3892/ijmm.2026.5761 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Medicine, 2026. Verfasst von Eliano Cascardi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), Section of Molecular Pathology, University of Bari, I-70121 Bari, Ital…. Hauptthemen laut MEDLINE: Mouth Neoplasms, Tumor Microenvironment, Carcinoma, Squamous Cell, Stromal Cells. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 157 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The tumor microenvironment (TME) in oral squamous cell carcinoma (OSCC) represents a dynamic and heterogeneous ecosystem in which non-immune stromal cells play important roles in tumor progression, invasion and therapeutic resistance. Among these, cancer-associated fibroblasts (CAFs), derived mainly from normal oral fibroblasts under the influence of tumor-derived cytokines such as transforming growth factor β (TGF-β), angiopoietin-like 3 and platelet-derived growth factor-BB, are the most abundant. CAFs exhibit a myofibroblastic phenotype characterized by α-smooth muscle actin, fibroblast activation protein and integrin α6 expression and their presence correlates with aggressive tumor behavior and poor prognosis. Functionally, CAFs contribute to the 'reverse Warburg effect', remodeling of the extracellular matrix via matrix metalloproteinases and lysyl oxidase, promotion of angiogenesis and immunosuppression through cytokines such as TGF-β, interleukin (IL) 6 and IL-10. Programmed death-ligand 1 (PD-L1), a key immune checkpoint molecule, suppresses T-cell activation by binding programmed death-1 (PD-1) on lymphocytes while also exerting intrinsic oncogenic functions, including enhancement of epithelial-mesenchymal transition, proliferation and resistance to radiotherapy and chemotherapy. PD-L1-enriched extracellular vesicles released by CAFs and tumor cells further propagate immune evasion and metastasis. Although PD-1/PD-L1 blockade with pembrolizumab or nivolumab has improved outcomes in advanced OSCC, variability in PD-L1 expression and intratumoral heterogeneity challenge predictive accuracy. The present review integrated stromal and immune perspectives, emphasizing the dual oncogenic and immunomodulatory roles of CAFs and PD-L1 in shaping the OSCC TME and identifying future therapeutic opportunities targeting both compartments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mouth NeoplasmsTumor MicroenvironmentCarcinoma, Squamous CellStromal CellsHumansDisease ProgressionCancer-Associated FibroblastsAnimalsCytokines

Stichwörter der Autor:innen

immunotherapymicroenvironmentoral squamous cell carcinomaprogrammed death-ligand 1

Substanzen

Cytokines

Autor:innen und Institutionen

  • Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), Section of Molecular Pathology, University of Bari, I-70121 Bari, Italy.
  • Department of Biomedical Sciences and Human Oncology, Section of Oncology, University of Bari, I-70121 Bari, Italy.
  • Department of Clinical and Experimental Medicine, University of Foggia, I-71122 Foggia, Italy.
  • Department of Precision Medicine, University of Campania Luigi Vanvitelli, I-80138 Naples, Italy.
  • Department of Biomedical and Neuromotor Sciences, University of Bologna, I-40125 Bologna, Italy.
  • Department of Life Science, Health and Health Professions, Link Campus University, I-00165 Rome, Italy.

Zitieren

APA

Cascardi, E., Della Mura, M., Sgarro, N., Minei, S., Cazzato, G., Maiorano, E., Lo Muzio, L., Bizzoca, M. E., Vieira E Silva, F. F., Lo Muzio, E., Dioguardi, M., & Ballini, A. (2026). Chorus line in oral squamous cell carcinoma: How stromal and immune players orchestrate tumor progression (Review). International Journal of Molecular Medicine. https://doi.org/10.3892/ijmm.2026.5761

Vancouver

Cascardi E, Della Mura M, Sgarro N, Minei S, Cazzato G, Maiorano E, et al. Chorus line in oral squamous cell carcinoma: How stromal and immune players orchestrate tumor progression (Review). International Journal of Molecular Medicine. 2026. doi:10.3892/ijmm.2026.5761

BibTeX
@article{Cascardi2026,
  author = {Cascardi, Eliano and Della Mura, Mario and Sgarro, Nicoletta and Minei, Silvia and Cazzato, Gerardo and Maiorano, Eugenio and Lo Muzio, Lorenzo and Bizzoca, Maria Eleonora and Vieira E Silva, Fábio França and Lo Muzio, Eleonora and Dioguardi, Mario and Ballini, Andrea},
  title = {Chorus line in oral squamous cell carcinoma: How stromal and immune players orchestrate tumor progression (Review)},
  journal = {International Journal of Molecular Medicine},
  year = {2026},
  doi = {10.3892/ijmm.2026.5761}
}
Kostenlos starten →